| Biostar Pharmaceuticals is a holding company. Through its wholly-owned subsidiary, Shaanxi Biostar Biotech, Ltd. and its variable interest entities Shaanxi Aoxing Pharmaceutical Co., Ltd. and Shaanxi Weinan Huaren Pharmaceuticals Ltd., Co. develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in China. Co.'s primary product is the XinAoxing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. As of Dec 31 2016, Co. manufactured and sold 12 OTC medications and 17 prescription-based pharmaceuticals which were sold and distributed in over 25 provinces and provincial-level cities throughout China. We show 9 historical shares outstanding datapoints in our BSPM shares outstanding history coverage, used to compute BSPM market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BSPM market cap history over the course of time is important for investors
interested in comparing BSPM's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BSPM versus a peer is one thing; comparing
BSPM market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BSPM can fluctuate over the course of history.
With this page we aim to empower investors researching BSPM by allowing them to research the BSPM market cap history.